Clinical Trial Update: Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating intravenous tirofiban as a neuroprotective strategy before endovascular thrombectomy in ischemic stroke. The study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• tirofiban (Aggrastat) (tirofiban)

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: Stroke, Ischemic | Phase 3 | Status: RECRUITING